Pregabalin Completed Phase 3 Trials for Peripheral Neuropathy / Human Immunodeficiency Virus (HIV) Infections Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00264875Open Label Safety And Efficacy Study Of Pregabalin In Subjects With Nerve Pain Asociated With Human Immunodeficiency Virus (HIV) Neuropathy
NCT00232141Study of Pregabalin Versus Placebo in the Treatment of Nerve Pain Associated With HIV Neuropathy